Published in Atherosclerosis on December 08, 2013
Endothelial fluid shear stress sensing in vascular health and disease. J Clin Invest (2016) 0.92
Endothelial Mechanosignaling: Does One Sensor Fit All? Antioxid Redox Signal (2016) 0.77
Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition. PLoS One (2015) 0.77
The arterial microenvironment: the where and why of atherosclerosis. Biochem J (2016) 0.77
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation. Cardiovasc Diabetol (2017) 0.75
Lack of Fibronectin Extra Domain A Alternative Splicing Exacerbates Endothelial Dysfunction in Diabetes. Sci Rep (2016) 0.75
Haemodynamics Regulate Fibronectin Assembly via PECAM. Sci Rep (2017) 0.75
Integrin signaling in atherosclerosis. Cell Mol Life Sci (2017) 0.75
Blood Brothers: Hemodynamics and Cell-Matrix Interactions in Endothelial Function. Antioxid Redox Signal (2016) 0.75
Disturbed Flow Promotes Arterial Stiffening Through Thrombospondin-1 (TSP-1). Circulation (2017) 0.75
EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis. Circulation (2017) 0.75
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol (2007) 17.18
Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol (2009) 6.11
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med (1998) 5.54
Trends in cardiovascular complications of diabetes. JAMA (2004) 4.74
Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol (2009) 4.58
Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev (2005) 2.46
Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A (1990) 2.18
The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. J Cell Biol (2005) 2.07
Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Circ Res (2008) 2.01
Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A (2005) 1.93
Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes (2002) 1.78
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest (2004) 1.73
Matrix-specific suppression of integrin activation in shear stress signaling. Mol Biol Cell (2006) 1.67
Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis. J Cell Biol (2007) 1.62
Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood (2004) 1.54
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia (2007) 1.46
Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol (2009) 1.40
Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation. Circ Res (2010) 1.29
Diabetic nephropathy and extracellular matrix. J Histochem Cytochem (2012) 1.28
p21-activated kinase signaling regulates oxidant-dependent NF-kappa B activation by flow. Circ Res (2008) 1.28
Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation (2001) 1.26
A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Arterioscler Thromb Vasc Biol (2011) 1.23
Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med (2012) 1.16
Arterial stiffness and extracellular matrix. Adv Cardiol (2007) 1.13
Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vasc Med (2012) 1.12
Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes (2003) 1.07
EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 1.02
Matrix-specific protein kinase A signaling regulates p21-activated kinase activation by flow in endothelial cells. Circ Res (2010) 1.01
Hemodynamic activation of beta-catenin and T-cell-specific transcription factor signaling in vascular endothelium regulates fibronectin expression. Arterioscler Thromb Vasc Biol (2011) 0.99
Vascular basement membrane thickening in diabetic retinopathy. Curr Eye Res (2010) 0.97
Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats. Invest Ophthalmol Vis Sci (2008) 0.95
Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset. Am J Cardiol (1980) 0.93
A long-term siRNA strategy regulates fibronectin overexpression and improves vascular lesions in retinas of diabetic rats. Mol Vis (2011) 0.89
Altered nitric oxide production mediates matrix-specific PAK2 and NF-κB activation by flow. Mol Biol Cell (2012) 0.88
Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function. Microsc Microanal (2012) 0.88
Shear stress modulates RAGE-mediated inflammation in a model of diabetes-induced metabolic stress. Am J Physiol Heart Circ Physiol (2012) 0.87
Spontaneously diabetic Ins2(+/Akita):apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis. Am J Physiol Endocrinol Metab (2011) 0.86
High glucose induced NF-kappaB DNA-binding activity in HAEC is maintained under low shear stress but inhibited under high shear stress: role of nitric oxide. Atherosclerosis (2003) 0.85
Elevated glucose attenuates agonist- and flow-stimulated endothelial nitric oxide synthase activity in microvascular retinal endothelial cells. Endothelium (2007) 0.79